Holen Sie sich die Stockscreener-App
30.08
0.03%
0.010
Schlusskurs vom Vortag:
$30.07
Offen:
$29.79
24-Stunden-Volumen:
1.05M
Relative Volume:
0.96
Marktkapitalisierung:
$12.74B
Einnahmen:
$6.18B
Nettoeinkommen (Verlust:
$626.40M
KGV:
20.96
EPS:
1.435
Netto-Cashflow:
$848.81M
1W Leistung:
-1.92%
1M Leistung:
-0.73%
6M Leistung:
-8.01%
1J Leistung:
+5.25%
1-Tages-Spanne:
$29.76
$30.23
1-Wochen-Bereich:
$29.76
$30.79
52-Wochen-Spanne:
$28.79
$38.79
Smith Nephew Plc Adr Stock (SNN) Company Profile
Firmenname
Smith Nephew Plc Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare SNN vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SNN
Smith Nephew Plc Adr
|
30.08 | 12.74B | 6.18B | 626.40M | 848.81M | 1.435 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Smith Nephew Plc Adr Stock (SNN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-10-14 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2025-04-25 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-03-12 | Herabstufung | UBS | Buy → Neutral |
| 2024-11-06 | Herabstufung | Berenberg | Buy → Hold |
| 2024-11-01 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-07-24 | Eingeleitet | Deutsche Bank | Buy |
| 2024-06-05 | Hochstufung | UBS | Neutral → Buy |
| 2023-11-28 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2023-11-03 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-10-31 | Hochstufung | HSBC Securities | Hold → Buy |
| 2023-10-13 | Eingeleitet | Stifel | Hold |
| 2023-08-08 | Hochstufung | UBS | Sell → Neutral |
| 2023-04-27 | Herabstufung | HSBC Securities | Buy → Hold |
| 2023-04-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-12-12 | Eingeleitet | Citigroup | Buy |
| 2022-11-28 | Herabstufung | UBS | Neutral → Sell |
| 2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-07-28 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-03-16 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-04 | Hochstufung | Redburn | Sell → Neutral |
| 2021-06-09 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-18 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2020-12-01 | Eingeleitet | Barclays | Overweight |
| 2020-07-29 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-06-04 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2019-11-21 | Eingeleitet | Citigroup | Buy |
| 2019-11-12 | Eingeleitet | Bernstein | Outperform |
| 2019-07-23 | Hochstufung | Berenberg | Hold → Buy |
| 2019-02-08 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2019-01-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-12-10 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-11-01 | Bestätigt | Canaccord Genuity | Buy |
| 2018-01-25 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-12-11 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2017-10-11 | Eingeleitet | Canaccord Genuity | Buy |
| 2017-02-27 | Herabstufung | Goldman | Buy → Neutral |
| 2017-01-19 | Eingeleitet | HSBC Securities | Hold |
| 2016-12-08 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2016-10-06 | Herabstufung | Berenberg | Buy → Hold |
| 2016-02-26 | Eingeleitet | Cantor Fitzgerald | Hold |
Alle ansehen
Smith Nephew Plc Adr Aktie (SNN) Neueste Nachrichten
Smith & Nephew StockThursday technical picture and trading range - AD HOC NEWS
Why Smith & Nephew’s PICO Single Use Negative Pressure System is changing tricky wound care - AD HOC NEWS
Why Smith & Nephew’s LEGION Revision Knee still matters in tough cases - AD HOC NEWS
Smith+Nephew announces first clinical cases with the next generation CORI◊XT Handheld Robotics Platform across knee and shoulder arthroplasty - Sahm
Smith & Nephew plc (ADR) stock (US83175M2052): U.K. medtech group draws interest after recent debt m - AD HOC NEWS
Smith & Nephew (NYSE: SNN) execs add ADS via dividend reinvestment - Stock Titan
Wound Irrigation Systems Market to Skyrocket USD 430.05 Million by 2035 as Chronic Wound Cases and Surgical Volumes Rise Worldwide | SNS Insider - GlobeNewswire Inc.
Dell Upgraded, Costco Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Smith+Nephew launch next generation LEAF™ Patient Monitoring System – an innovative pressure injury prevention platform delivering proven clinical impact - Sahm
Smith & Nephew plc stock (GB0009223206): orthopedics specialist lifts guidance after solid Q1 - AD HOC NEWS
Smith & Nephew stock (GB0009223206): sets sterling final dividend ahead of May payout - AD HOC NEWS
Smith & Nephew stock (GB0009223206): +2.75% gain to 1,103 GBX - AD HOC NEWS
DowngradesStock ScreenerSnapshot - Finviz
Smith+Nephew’s REGENETEN◊ Bioinductive Implant shows post-operative recovery times halved, and high healing rates for partial-thickness rotator cuff tears1,* - Sahm
New data for Smith+Nephew’s CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant demonstrates superior pain relief and functional gains at 5-years - ChartMill
Smith & Nephew plc (ADR) stock (US83175M2052): Why Google Discover changes matter more now for medte - AD HOC NEWS
Smith & Nephew plc (ADR) stock (US83175M2052): Why its medtech innovation edge is suddenly worth a c - AD HOC NEWS
Smith & Nephew PLC (NYSE:SNN) Passes the Caviar Cruise Screen for Quality Investing - ChartMill
Smith & Nephew plc (ADR) Stock: Global Medtech Leader Faces Evolving Orthopedics and Sports Medicine - AD HOC NEWS
Smith & Nephew plc (ADR) stock faces pressure amid regulatory hurdles and slowing ortho demand - AD HOC NEWS
Smith & Nephew plc (ADR) Stock (ISIN: US83175M2052) Faces Headwinds Amid Medtech Sector Slowdown - AD HOC NEWS
Smith+Nephew launches next-generation ALLEVYN COMPLETE CARE Foam Dressingdesigned for high performance in wound management and pressure injury prevention - Finviz
Smith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressingdesigned for high performance in wound management and pressure injury prevention - ChartMill
NVIDIA Upgraded, Eli Lilly Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Smith+Nephew to feature leading rotator cuff repair portfolio including new Tendon Seam™ Repair System and REGENETEN◊ Bioinductive Implant at AAOS 2026 - Sahm
Smith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026 - Sahm
Smith+Nephew to feature leading rotator cuff repair portfolio including new Tendon Seam Repair System and REGENETEN◊ Bioinductive Implant at AAOS 2026 - Finviz
Smith & Nephew FTSE Healthcare Market Presence and Operational Developments - Kalkine Media
Smith+Nephew signs exclusive US distribution agreement with RMR Ortho for patented technology that provides a unique dynamic compression nitinol fixation option (A'TOMIC) to our surgeons - Finviz
Smith+Nephew signs exclusive US distribution agreement with RMR Ortho for patented technology that provides a unique dynamic compression nitinol fixation option (A'TOMIC™) to our surgeons - Sahm
Smith+Nephew signs distribution agreement with SI-BONE - Finviz
Factory Mutual Insurance Co. Buys New Stake in Smith & Nephew SNATS, Inc. $SNN - Defense World
Smith & Nephew (NYSE: SNN) leaders add ADS via plan - Stock Titan
Jim Cramer on Smith & Nephew: "This Group, I Do Not Like" - Finviz
Jim Cramer on Smith & Nephew: “This Group, I Do Not Like” - Insider Monkey
Smith+Nephew completes acquisition of Integrity Orthopaedics; establishes unrivalled portfolio for shoulder repair - Finviz
The Truth About Smith & Nephew plc: Why This ‘Boring’ Med-Tech Stock Might Be Your Sneaky Power - AD HOC NEWS
Finanzdaten der Smith Nephew Plc Adr-Aktie (SNN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):